Categories: Coronavirus

J&J COVID-19 vaccine pause ends

The FINANCIAL — On Friday, April 23, the Advisory Committee on Immunization Practices (ACIP), an independent immunization advisory group for the Centers for Disease Control and Prevention, voted to resume distribution of the Johnson & Johnson (J&J) COVID-19 vaccine after a 10-day pause to investigate reported cases of rare blood clotting events in recipients, Mayo Clinic notes.

The committee met twice to evaluate and review the data from the rare adverse event cases reported so far. The new term for this serious blood clotting disorder is “thrombosis with thrombocytopenia syndrome,” also known as TTS.”

The committee assessed the risk of this syndrome, the benefits of the vaccine, and the potential for additional COVID-19 hospitalizations and deaths from disrupting or slowing vaccinations. Based on the group’s evaluation, the recommendation for health care providers is to resume distribution of the J&J COVID-19 vaccine and provide education to patients about the new Food and Drug Administration warning and precaution regarding thrombosis with thrombocytopenia, and continue to watch for, evaluate and report any blood clotting cases.

“Dr. Melanie Swift and I were able to listen to both ACIP meetings and deliberations,” says Dr. Abinash Virk, co-chair of Mayo Clinic COVID-19 Vaccine Allocation and Distribution Work Group. “The key facts to focus on are the U.S.’ system to identify serious adverse effects, including rare ones like TTS, is very robust and reliable, and the ACIP review of the data overwhelmingly showed that the benefits greatly outweigh the risk of the J&J vaccine at a population and individual level.”

“I’m glad that we will continue to have this vaccine as an important tool to help end the pandemic,” says Dr. Melanie Swift, co-chair of Mayo Clinic’s COVID-19 Vaccine Allocation and Distribution Work Group. “The risk of TTS is incredibly low and on a par with other risks we tolerate all the time. This decision gives patients the ability to make informed decisions, and many people really want to be able to take a one-dose vaccine.”

Mayo Clinic is committed to patient safety and will take the time required to thoughtfully plan a process and education for patients before resuming distribution of this vaccine, Mayo Clinic notes.

The risk for thrombosis with thrombocytopenia syndrome is rare overall — an estimated 1 in 520,000 for women under 50 and 1 in 143,000 for women 18–49.

“In fact, the risk is very similar in number to other rare serious adverse effects with many other medications that are commonly taken by patients. We will work on educating our health care providers, patients and community about the risks to allow people to safely make informed decisions,” says Dr. Virk.

If you receive the J&J COVID-19 vaccine and experience unexplained new severe symptoms after 72 hours and up to three weeks after vaccination, such as new severe headaches, leg pain, abdominal pain or shortness of breath, you should seek emergency care.

Note: Experiencing mild to moderate headache and muscle aches are common in the first three days after vaccination and do not require emergency care.


Since 2005

Recent Posts

Now is Not the Time for the CDC to Relax Opioid Prescription Guidelines

This month, the Centers for Disease Control and Prevention (CDC) released their 2022 exit disclaimer…

10 hours ago

Biden-Harris Administration Awards $5.5 Million to Rhode Island in ‘Internet for All’ Planning Grants

The Department of Commerce’s National Telecommunications and Information Administration (NTIA) announced that Rhode Island received…

11 hours ago

Christmas Events in Philly

Featured Events in Philly Holiday Tree Lighting Celebration Kick off the season with the Holiday…

11 hours ago

Camel Coronavirus Poses Threat To Fans At 2022 World Cup In Qatar

Up to 1.5 million visitors from all continents will be heading to Qatar to watch…

11 hours ago

Georgia Experiencing shortage of flu, strep medicine as cases rise

The FINANCIAL -- Country of Georgia is left with no medicines for children, as cases of…

1 day ago

In Georgia, health workers prepare for busy winter season amid COVID-19 and influenza surge concerns

“Does it hurt?” asks Lela Beradze kindly as she administers an influenza vaccine to a…

1 day ago